NCI (01336) Sets 27 Mar 2026 Board Meeting to Approve FY 2025 Results and Final Dividend

Bulletin Express
03/17

New China Life Insurance Company Ltd. (stock code: 01336, “NCI”) has scheduled a board meeting for Friday, 27 March 2026. The agenda includes the review and approval of the consolidated annual results for the financial year ended 31 December 2025, authorisation for the publication of these results, consideration of a final dividend proposal, and the handling of other routine business matters.

The notice, dated 17 March 2026, was signed by Chairman Yang Yucheng. The current board comprises Chairman and Executive Director Yang Yucheng; Executive Director Gong Xingfeng; Non-Executive Directors Yang Xue, Mao Sixue, Hu Aimin and Zhang Xiaodong; and Independent Non-Executive Directors Ma Yiu Tim, Xu Xu, Guo Yongqing and Zhuo Zhi.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10